Market Cap

$17.1M

Volume

15.1K

Cash and Equivalents

$25.4M

EBITDA

-$71.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$15.7M

Profit Margin

99.85%

52 Week High

$28.50

52 Week Low

$1.10

Dividend

N/A

Price / Book Value

-1.18

Price / Earnings

-0.23

Price / Tangible Book Value

-1.18

Enterprise Value

$32.5M

Enterprise Value / EBITDA

-0.46

Operating Income

-$71.8M

Return on Equity

-367.00%

Return on Assets

-56.45

Cash and Short Term Investments

$25.8M

Debt

$41.2M

Equity

-$14.5M

Revenue

$15.8M

Unlevered FCF

-$49.8M

Sector

Biotechnology

Category

N/A